vTv Therapeutics Announces 2020 First Quarter Financial Results and Update
May 07, 2020 16:30 ET
|
vTv Therapeutics Inc.
HIGH POINT, N.C., May 07, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the first quarter ended March 31, 2020, and provided an update on recent...
vTv Therapeutics Announces 2019 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
February 20, 2020 18:57 ET
|
vTv Therapeutics Inc.
HIGH POINT, N.C., Feb. 20, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the fourth quarter and year ended December 31, 2019, and provided an...
Insulin Market To Reach USD 35.74 Billion By 2027| Reports And Data
January 13, 2020 09:33 ET
|
Reports and Data
New York, Jan. 13, 2020 (GLOBE NEWSWIRE) -- The global Insulin Market is forecast to reach USD 35.74 Billion by 2027, according to a new report by Reports and Data. Insulin therapy is used for the...
NobleCon Investor Conference: Country Star Eric Paslay Joins Type 1 Diabetes Panel Presentation Entitled “A Functional Cure Could Be Imminent”
December 10, 2019 12:41 ET
|
Noble Financial Group, Inc.
FORT LAUDERDALE, Fla., Dec. 10, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Noble Capital Markets, Inc. (“Noble”) announced today that country star Eric Paslay (with hits like “Friday Night”) will...
vTv Therapeutics Announces 2019 Third Quarter Financial Results and Update
October 30, 2019 17:30 ET
|
vTv Therapeutics Inc.
SimpliciT-1 Study of TTP399 in patients with type 1 diabetes fully-enrolled Elevage Study of azeliragon in patients with mild Alzheimer’s disease with type 2 diabetes actively enrolling HIGH POINT,...
Déclaration de Dave Prowten, président et chef de la direction de FRDJ Canada
August 12, 2019 11:15 ET
|
Fondation de la recherche sur le diabète juvénile
TORONTO, 12 août 2019 (GLOBE NEWSWIRE) -- FRDJ suit de très près les développements en ce qui a trait à la récente annonce du Safe Importation Action Plan du Département de la Santé et des...
Statement by Dave Prowten, President and CEO JDRF Canada
August 12, 2019 11:15 ET
|
Juvenile Diabetes Research Foundation Canada
TORONTO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- JDRF has been closely monitoring developments rising from the recent announcement of a “Safe Importation Action Plan” by the United States Department of...
T1D Exchange Teams with Tidepool to Leverage Device Data for Groundbreaking Study of Type 1 Diabetes
November 29, 2018 07:45 ET
|
T1D Exchange
BOSTON, Nov. 29, 2018 (GLOBE NEWSWIRE) -- T1D Exchange today announced a research partnership with Tidepool to better understand the link between patient reported experiences and the mild and...
T1D Exchange Launches One-Stop Resource for the Type 1 Diabetes Community
November 08, 2018 07:45 ET
|
T1D Exchange
New Website Puts Patients at the Center of Accelerating Innovation and Improving Care BOSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- T1D Exchange today announced the launch of a new T1DExchange.org...
JDRF celebrates Health Canada’s new licence for technology that will improve the lives of people with type 1 diabetes
October 10, 2018 14:56 ET
|
Juvenile Diabetes Research Foundation Canada
Approval of Canada’s first Hybrid Closed-Loop System will help Canadians with type 1 diabetes keep their blood sugar levels in an optimal range for a greater amount of time TORONTO, Oct. 10, 2018 ...